SWISSMEMBRANE
LIVE

Serial Number

98865916

Owner

Geistlich Pharma AG

Attorney

George R. Repper

Filing Date

Nov 21, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SWISSMEMBRANE Trademark

Serial Number: 98865916

SWISSMEMBRANE is a trademark filed by Geistlich Pharma AG on November 21, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Geistlich Pharma AG (2 trademarks)

Bahnhofstrasse 40
Wolhusen CH-6110 , CH

Entity Type: 99

Trademark Details

Filing Date

November 21, 2024

Registration Date

Not Registered

Goods & Services

Pharmaceutical and veterinary preparations and substances for treating skin disorders, tooth loss, trauma or tumor resection, bone defect or loss, cartilage defects, chondral and osteochondral lesions, meniscal lesions, diabetes; hemostatic products, namely, dental hemostatic paste, medical hemostatic paste, hemostatic pencils; wound dressing material, namely, hemostatic gel matrix preparations for treating wounds, pharmaceutical preparations for treating wounds, liquid bandages for skin wounds; vulnerary sponges; tissue adhesives for medical purposes, namely, medical adhesives for binding internal tissue, medical adhesives tapes for binding wounds; filling and implant materials of natural origin for dental, maxillofacial and orthopedic surgery, especially for the regeneration of soft tissue, namely skin grafts, processed human donor skin for the replacement of soft tissue; medical plasters and medical dressings; collagen for medical purposes, namely, biocompatible collagen-material, in particular biocompatible collagen-membranes, biocompatible collagen-matrixes or biocompatible collagen-sponge for use in dental, maxillofacial and orthopedic surgery, especially for the regeneration of soft tissue, or for use as a hemostatic agent in surgery

Surgical, medical, dental and veterinary apparatus and instruments for use in orthopedic surgery, oral surgery, maxillofacial surgery; biocompatible collagen-material, in particular biocompatible collagen-membranes, biocompatible collagen-matrixes or biocompatible collagen-sponge, namely, collagen barrier membranes for oral, maxillofacial and orthopedic surgical procedures, especially for the regeneration of soft tissue, or for use as a hemostatic agent in surgery; surgical implants and surgical sponges comprised of synthetic collagen materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies

Filing History

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Apr 27, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Apr 27, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Apr 27, 2026 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 25, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 25, 2025 GNSL
SUSPENSION LETTER WRITTEN
Sep 25, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 8, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 8, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 16, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 16, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 16, 2025 CNRT
ASSIGNED TO EXAMINER
May 15, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Nov 21, 2024 MAFR
NEW APPLICATION ENTERED
Nov 21, 2024 NWAP